Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea

PURPOSE: Omalizumab, an anti-immunoglobulin E (IgE) monoclonal antibody, has proved to be effective for the treatment of severe asthma. However, there is no direct evidence of effectiveness of omalizumab in Korean patients with severe asthma. We sought to evaluate the real-world effectiveness of oma...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Allergy Asthma Immunol Res
Main Authors: Lee, Ji-Ho, Lee, Hyun Young, Jung, Chang-Gyu, Ban, Ga-Young, Shin, Yoo Seob, Ye, Young-Min, Nahm, Dong-Ho, Park, Hae-Sim
פורמט: Artigo
שפה:Inglês
יצא לאור: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2018
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5809760/
https://ncbi.nlm.nih.gov/pubmed/29411552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4168/aair.2018.10.2.121
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים